crisi
call
rapid
reaction
field
biomed
research
tradit
drug
develop
involv
time
consum
pipelin
conflict
urgenc
identifi
effect
therapi
health
econom
emerg
drug
reposit
discoveri
new
clinic
applic
drug
alreadi
approv
differ
therapeut
context
could
provid
effect
shortcut
bring
treatment
bedsid
time
manner
moreov
comput
approach
help
acceler
process
even
present
applic
differ
softwar
tool
base
transcriptom
data
identifi
drug
potenti
abl
counteract
infect
also
provid
insight
mode
action
believ
hdac
inhibitor
warrant
investig
addit
found
dna
mismatch
repair
pathway
strongli
modul
drug
experiment
vitro
activ
infect
drug
reposit
drug
repurpos
aim
find
new
clinic
applic
drug
alreadi
use
differ
purpos
usual
drug
repurpos
known
potenti
therapeut
target
select
experiment
search
exist
compound
abl
modul
target
activ
perform
comput
drug
repurpos
offer
complementari
approach
prioritis
compound
experiment
valid
sever
differ
method
propos
literatur
alreadi
appli
broadli
classifi
method
search
small
molecul
abl
bind
activ
pocket
start
threedimension
structur
target
protein
search
compound
abl
modul
express
target
mrna
exist
drug
reposit
pipelin
focu
former
approach
use
latter
identifi
fda
approv
drug
abl
modul
express
gene
express
airway
epithelium
known
interact
protein
next
attempt
complet
agnost
approach
tri
identifi
drug
revers
gene
express
profil
induc
infect
final
investig
potenti
effect
mechan
action
identifi
molecular
pathway
consist
dysregul
set
drug
recent
propos
effect
reduc
n
protein
level
treat
vero
cell
applic
proper
comput
tool
thu
abl
identifi
set
drug
experiment
valid
may
potenti
benefici
role
treatment
togeth
insight
mechan
action
could
help
identifi
effect
target
infect
recent
shown
tha
entri
host
cell
mediat
receptor
requir
prime
proteas
thu
sought
identifi
drug
could
potenti
reduc
express
gene
although
benefit
approach
debat
end
appli
comput
drug
reposit
approach
name
tool
comput
enrich
score
es
correspond
pvalu
small
molecul
connect
map
dataset
broad
institut
includ
fda
approv
drug
base
much
tend
upor
downregul
gene
interest
well
gene
involv
pathway
result
analysi
identifi
drug
shown
tabl
p
drug
potenti
relev
carbenoxolon
shown
antivir
activ
dengu
viru
indomethacin
nonsteroid
antiinflammatori
drug
nsaid
inhibit
prostaglandin
synthas
demonstr
efficaci
sarscov
interestingli
recent
studi
viral
found
interact
thu
author
suggest
indomethacin
potenti
use
treat
patient
howev
indomethacin
select
appear
lower
express
gene
pathway
includ
therefor
indomethacin
could
high
prioriti
molecul
test
could
doubl
effect
anoth
nsaid
present
among
drug
identifi
tabl
nimesulid
could
similar
effect
indomethacin
also
identifi
nicarpidin
angiotensin
inhibitor
obviou
candid
found
use
pure
datadriven
approach
antipsychot
agent
specif
dopamin
receptor
effect
treatment
schizophrenia
tabl
drug
predict
downregul
gene
tool
p
enrich
score
es
correspond
pvalu
pv
report
drug
anoth
potenti
effect
approach
identif
therapeut
agent
counteract
infect
target
hostviru
interact
order
investig
cellular
protein
interact
viral
protein
perform
affin
purificationmass
spectrometri
analysi
identifi
total
protein
interact
protein
plu
mutant
human
protein
sinc
interact
could
key
hijack
host
cours
infect
sought
priorit
exist
drug
potenti
interf
particular
appli
time
exploit
geneset
wise
analysi
capabl
specif
viral
protein
gener
correspond
geneset
contain
host
protein
interactor
thu
obtain
geneset
appli
identifi
compound
abl
downregul
express
gene
across
geneset
time
appear
particularli
effect
strategi
given
current
limit
understand
specif
infect
mechan
top
hit
report
tabl
interestingli
one
hit
niclosamid
antihelminth
drug
found
antivir
efficaci
recent
screen
use
vero
cell
notabl
candid
found
analysi
fenoterol
also
identifi
potenti
effect
recent
studi
comput
drug
reposit
alexidin
antibiot
select
inhibitor
mitochondri
phosphatas
found
inhibit
replic
cytomegaloviru
cmv
infect
oxytetracyclin
anoth
antibiot
shown
antivir
activ
dengu
viru
abil
reduc
rna
transcript
within
extracellular
vescicl
clofibr
peroxisomeprolifer
activ
receptoralpha
ppar
agonist
previous
use
cholesterollow
agent
found
antivir
activ
mdv
alphaherpesviru
infect
chicken
caus
deadli
lymphoma
flupentixol
neurolept
agent
found
inhibit
hepat
c
viru
entri
coxsackieviru
replic
gossypol
natur
phenol
deriv
cotton
plan
known
inhibit
spermatogenesi
shown
also
antivir
activ
trichostatin
histon
deacetylas
inhibitor
hdaci
latter
found
inhibit
express
herp
simplex
viru
gene
interestingli
valproic
acid
anoth
hdaci
propos
reposit
viral
protein
found
interact
role
serotonerg
antagonist
serotonerg
drug
serotonin
uptak
trypanothionedisulfid
reductas
inhibitor
antidepress
tabl
drug
predict
downregul
human
interactor
tool
p
top
report
mean
enrich
score
es
correspond
mean
pvalu
pv
across
differ
geneset
backgroun
see
method
report
drug
datadriven
approach
drug
reposit
identifi
compound
abl
revert
diseaserel
signatur
develop
mantra
tool
exploit
cmap
dataset
broad
institut
gener
explor
drug
network
drug
reposit
drug
network
node
repres
druginduc
transcript
profil
edg
repres
similar
sought
use
approach
priorit
drug
revert
induc
gene
express
wholegenom
level
without
assum
knowledg
molecular
mechan
involv
diseas
progress
recent
gene
express
profil
primari
human
bronchial
epitheli
nhbe
infect
made
publicli
avail
geo
databas
obtain
correspond
raw
data
comput
differenti
express
infect
non
infect
cell
gene
significantli
differenti
express
adjust
p
overexpress
infect
cell
includ
interleukin
chemokin
interferon
alpha
induc
protein
mantra
approach
base
gene
set
enrich
analysi
therefor
requir
input
list
measur
gene
rank
accord
differenti
express
includ
signific
nonsignific
gene
thu
sort
gene
accord
differenti
express
gene
downregul
follow
infect
top
list
upregul
bottom
queri
mantra
drug
network
profil
look
drug
induc
similar
transcript
profil
therefor
may
potenti
induc
profil
opposit
infect
thu
found
signific
drug
transcript
distanc
list
tabl
one
drug
sirolimu
also
known
rapamycin
inhibitor
mechanist
target
rapamycin
complex
use
clinic
immunosuppress
agent
obviou
candid
kind
drug
reposit
aim
find
drug
induc
opposit
repsons
viru
gene
overexpress
viral
infect
immunerel
cours
mean
clinic
relev
suppress
immun
respons
could
detriment
cell
nevertheless
rapamycin
also
suggest
interactor
studi
base
nuclecapsid
interact
mtor
translat
repressor
rapamycin
report
vitro
activ
mer
interest
candid
found
mantra
ambroxol
mucolyt
agent
report
antivir
activ
influenzaviru
among
other
chlorzoxazon
corticosteron
glucocorticoid
idoxuridin
nucleosid
analogu
use
inhibit
replic
dna
virus
naltrexon
muopiod
receptor
antagonist
use
opioid
alcohol
depend
report
antiinflammatori
effect
nordihydroguaiaret
acid
antioxid
compound
found
creosot
bush
larrea
tridentata
report
antivir
activ
west
nile
zika
virus
aromat
amin
use
treatment
respiratori
diseas
associ
viscid
excess
mucu
veterinari
coccidiostat
interfer
thiamin
metabol
potent
blocker
enac
channel
also
sodiumcalcium
exchang
blocker
central
act
muscl
relax
sed
properti
use
symptomat
treatment
pain
muscl
spasm
steroid
hormon
corticosteroid
type
first
gener
ethanolamin
antiinflammatori
sed
antihistamin
properti
idoxuridin
antivir
drug
dna
synthesi
inhibitor
antivir
activ
herp
simplex
viru
hsv
potenti
radiosensit
activ
meptazinol
opioid
analges
muopioid
receptor
antagonist
use
treat
alcohol
depend
also
role
central
nervou
system
depress
environment
contamin
xenobiot
antidot
opioid
poison
role
antioxid
plant
metabolit
antibiot
role
immunosupress
antineoplast
antibacteri
agent
mtor
inhibitor
bacteri
metabolit
tabl
drug
predict
revert
transcript
signatur
induc
infect
mantra
tool
distanc
invers
profil
understand
biolog
mechan
underli
patholog
condit
molecular
level
greatli
help
identif
potenti
effect
drug
one
way
obtain
knowledg
analysi
exist
small
molecul
observ
elicit
vari
level
therapeut
effect
autom
screen
although
mode
action
posit
hit
largescal
drug
screen
difficult
identifi
like
hidden
mechan
share
among
hit
order
investig
exploit
assumpt
previous
develop
drug
set
enrich
analysi
dsea
dsea
abl
highlight
molecular
pathway
consist
specif
dysregul
drug
set
analyz
druginduc
express
profil
cmap
dataset
broad
institut
order
identifi
compound
abl
counteract
infect
jeon
et
al
recent
screen
collect
small
molecul
previous
observ
potenti
effect
sarscov
infect
plu
drug
suggest
infecti
diseas
specialist
among
screen
drug
show
reduct
n
protein
level
infect
vero
cell
drug
ten
present
cmap
dataset
use
dsea
amodiaquin
ciclosporin
desoxycorton
digoxin
loperamid
mefloquin
niclosamid
ouabain
proscillaridin
tetrandrin
thu
sought
analyz
drug
dsea
tool
order
understand
common
mechan
action
underli
antivir
effect
drug
found
dsea
modul
target
transcript
factor
tf
shown
tabl
includ
nfkb
master
regul
stress
respons
tf
involv
integr
stress
respons
known
role
enhanc
herpesviru
gene
express
member
stat
famili
activ
respons
cytokin
growth
factor
dsea
also
highlight
sever
biolog
process
modul
drug
tabl
among
relat
dna
mistmatch
repair
pathway
mmr
interestingli
dna
mmr
recent
report
requir
host
innat
respons
follow
influenza
viru
infect
tabl
drug
set
enrich
analysi
result
small
molecul
show
lower
level
n
protein
report
pathway
consist
dysregul
drug
set
found
dsea
base
analysi
induc
transcriptom
top
pathway
report
transcript
factor
target
collect
three
gene
ontolog
collect
enrich
score
es
correspond
pvalu
pv
report
gene
set
comput
method
drug
reposit
could
narrow
search
effect
drug
counteract
novel
epidem
show
number
exist
tool
use
toward
aim
cover
differ
approach
target
host
protein
interact
viral
protein
revers
diseaseinduc
transcript
mode
action
investig
drug
vitro
activ
infect
overal
found
compound
could
test
experiment
among
nsaid
antihistamin
antibiot
antihelmint
antipsychot
corticosteroid
hdac
inhibitor
hdaci
interest
found
interact
protein
screen
inhibitor
infect
vero
cell
identifi
sever
member
cardiac
glycosid
effect
cardiac
glycosid
recent
found
strong
hdaci
activ
therefor
interest
verifi
experiment
whether
hdaci
benefici
role
reduc
viral
replic
host
cell
final
interrog
possibl
mode
action
posit
hit
drug
screen
vero
cell
identifi
dna
mmr
pathway
possibl
involv
mode
action
drug
therefor
hint
pathway
could
involv
host
respons
viral
infect
use
comput
tool
share
databas
drug
induc
gene
express
profil
includ
connect
map
cmap
cmap
data
produc
use
affymetrix
micrarray
preprocess
abtain
express
valu
gene
moreov
express
profil
induc
drug
across
differ
replic
experiment
condit
merg
togeth
singl
consensu
profil
detail
preprocess
report
dsea
use
pathwaybas
version
cmap
pathwaybas
express
profil
pep
obtain
gene
express
profil
gep
iter
appli
gene
set
enrich
analysi
gsea
gep
pathway
databas
gene
ontolog
kegg
particular
tool
use
pathway
collect
includ
msigdb
see
detail
process
publicli
avail
onlin
implement
use
identifi
drug
downregul
tool
automat
identifi
gene
set
involv
input
gene
across
pathway
databas
also
dsea
analysi
use
onlin
tool
sinc
analysi
appli
human
molecular
interactor
requir
custom
perform
offlin
use
bioconductor
packag
particular
interactor
protein
use
defin
gene
set
obtain
gene
set
ad
pathway
collect
includ
latest
version
msigdb
final
cmap
gep
convert
pep
base
newli
creat
gene
set
collect
order
priorit
drug
accord
pep
analysi
perform
relat
gene
set
use
msigdb
gene
set
statist
background
sinc
statist
background
differ
gene
set
collect
averag
score
comput
obtain
final
priorit
drug
predict
revers
induc
signatur
identifi
use
publicli
avali
mantra
tool
rnaseq
raw
count
identif
differenti
express
gene
deg
respons
download
geo
databas
access
number
raw
count
first
normal
use
edger
deg
identifi
use
limma
packag
voom
method
r
statist
environ
obtain
gep
ad
mantra
network
use
revers
node
featur
way
gep
revers
upregul
gene
appear
downregul
viceversa
closest
node
network
correspond
drug
induc
opposit
gep
compar
twodimension
structur
imag
annot
report
tabl
obtain
pubchem
databas
